Weinberg Uri
- SEC CIK
- 0001811030
In the past year, 2 open-market sale filings worth $232.2K and no purchases.
Current role at each company
- NVCR NovoCure LtdChf Medical and Innovation Ofras of Mar 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $232.2K
- 2 filings
- Net
- −$232.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Weinberg Uri as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Weinberg UriChf Medical and Innovation Ofr | SSale | −6.41K | $13.31 | −$85.3K | −2.3%267.2K after | |
| Mar 3, 2026 (view filing) | Feb 27-Mar 2 | 4 days | Weinberg UriChf Medical and Innovation Ofr | SSale | −10.7K | $13.68 | −$146.9K | −4.6%223.5K after | 2 lots |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Weinberg UriChief Innovation Officer | SSale | −268 | $18.92 | −$5.07K | −0.2%166.2K after | |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Weinberg UriChief Innovation Officer | SSale | −4.64K | $18.75 | −$86.9K | −2.7%166.5K after | Amended2 lots |
| Jan 9, 2023 (view filing) | Jan 5 | 4 days | Weinberg UriChief Science Officer | SSale | −8.14K | $116.14 | −$945.8K | −15.8%43.3K after | 4 lots |